About this conference
This world congress represents a premier gathering of biotechnologists, geneticists, molecular biologists, clinical researchers, and healthcare professionals dedicated to advancing the frontiers of biotechnology, genomic science, and precision medicine. The congress program covers fundamental and applied research in areas such as gene editing technologies, next-generation sequencing, transcriptomics, proteomics, metabolomics, epigenomics, and systems biology. In the domain of precision medicine, the congress addresses biomarker discovery, pharmacogenomics, companion diagnostics, targeted therapies, immunotherapies, cell-based therapies, and regenerative medicine. The program also explores bioinformatics tools, computational genomics, data integration platforms, and artificial intelligence applications in genomic data analysis. Clinical implementation challenges, regulatory pathways, ethical considerations, patient stratification strategies, and health economic evaluations are also discussed. Through plenary lectures, parallel scientific sessions, poster presentations, and industry symposia, this congress aims to accelerate the translation of genomic discoveries into clinical practice, ultimately improving patient outcomes through personalized diagnostic and therapeutic approaches.